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Our objective is to develop a rapid and sensitive assay based on magnetic beads to detect the concentration of
influenza H3N2. The possibility of using variable domain heavy-chain antibodies (nanobody) as diagnostic tools for
influenza H3N2 was investigated. A healthy camel was immunized with inactivated influenza H3N2. A nanobody
library of 8 × 108 clones was constructed and phage displayed. After three successive biopanning steps, H3N2-specific
nanobodies were successfully isolated, expressed in Escherichia coli, and purified. Sequence analysis of the nanobodies
revealed that we possessed four classes of nanobodies against H3N2. Two nanobodies were further used to prepare
our rapid diagnostic kit. Biotinylated nanobody was effectively immobilized onto the surface of streptavidin magnetic
beads. The modified magnetic beads with nanobody capture specifically influenza H3N2 and can still be recognized
by nanobodies conjugated to horseradish peroxidase (HRP) conjugates. Under optimized conditions, the present
immunoassay exhibited a relatively high sensitive detection with a limit of 50 ng/mL. In conclusion, by combining
magnetic beads with specific nanobodies, this assay provides a promising influenza detection assay to develop a
potential rapid, sensitive, and low-cost diagnostic tool to screen for influenza infections.
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Influenza A and B viruses cause a pandemic threat to
human health throughout the world [1]. Sporadic trans-
mission of influenza viruses from birds to humans could
lead to unpredictable pandemic outbreaks. Influenza is
an infectious disease of the respiratory tract that can in-
fect millions of people and kills hundreds of thousands
of them [2]. Humans, infected with influenza A, ma-
nifest typically an acute upper respiratory tract illness
characterized by fever, cough, and sore throat. Disease
severity depends mainly on the virulence of the influenza
virus strain and immune competence of the patients [3].
Influenza viruses are members of the Orthomyxoviridae
family, and they are further classed as A, B, and C vi-
ruses [4]. Until now, 17 influenza A hemagglutinin (HA)
subtypes have been described. However, only a limited* Correspondence: xinshaojie@163.com; ywansystemsbiology@gmail.com
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in any medium, provided the original work is pnumber of influenza A viruses (IAV), such as H1, H2, H3,
H5, H6, H7, and H9, have been implicated with human in-
fection [5]. The high mutational rate of the virus and fre-
quency of interspecies transmission leading to novel virus
subtypes will reduce the current vaccine efficacy and make
influenza infection highly unpredictable [6,7].
Due to a broad vaccine deficiency, effective, early, and
sensitive detection of all subtypes of influenza A viruses
is of significant importance to reduce the mortality of in-
fluenza infection [8]. Simple equipment for the fast and
low-cost detection of influenza viruses can attract great
attention, because such a tool could reveal the threat be-
fore spreading the disease [9]. Diagnostic methods to de-
tect the influenza virus have been reported in several
studies. Isolation and cultivation of viruses in cell culture
has been regarded as the golden standard for virus de-
tection [10]. However, this method is laborious and
time-consuming, and it will take several days to identify
the virus. Besides cultivation assays, enzyme-linked im-
munosorbent assay (ELISA) using monoclonal antibo-
dies against influenza viral antigens is a good alternativeOpen Access article distributed under the terms of the Creative Commons
g/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction
roperly credited.
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other method used for influenza detection, is more spe-
cific, more sensitive, and less time-consuming, compared
with traditional methods [12]. However, all of the above
methods require sophisticated equipment and are not
practical in clinical settings. Therefore, the development
of a simple, rapid, and sensitive assay to detect influenza
remains a challenge.
Antibody-mediated immunoassays are promising tools
for the detection of influenza based on their specificity,
accuracy, and stability. Camelidae such as camels, llamas,
and alpacas have a humoral immune response that has
evolved into heavy-chain-only antibodies. Unlike conven-
tional IgGs, the antigen-binding fragment of these heavy-
chain antibodies consists of one single domain referred to
as VHH or nanobody, with a molecular weight of approxi-
mately 15 kD. A nanobody is one of the smallest known
antigen-binding antibody fragment. The CDR3 (the third
antigen-binding loop) of nanobodies plays a key role in
recognizing complicated structures such as pockets and
clefts that are usually inaccessible for conventional anti-
bodies [13]. The reduced size, improved solubility, and
good stability of the camelid heavy-chain fragments form
the basis of a new generation of antibodies for diagnostic
applications [14,15]. In our previous study, we have iso-
lated nanobodies against human prealbumin (PA) and
successfully applied them into a sensitive flow injection
chemiluminescence immunoassay with a detection limit
of 0.01 μg/L [16]. In addition, a nanobody with specificity
to small caffeine molecules has been used in an ELISA to
measure caffeine concentration in beverages [17]. Thus,
nanobodies provide great alternatives to conventional
antibodies for diagnosis of diseases.
In this study, we have successfully constructed an im-
mune phage display nanobody library against influenza
H3N2. The size of the nanobody library is 8 × 108 trans-
formants with great diversity. After several rounds of bio-
panning steps, nanobodies specific to H3N2 have been
isolated and expressed efficiently in bacterial hosts. More-
over, a novel immunoassay has been developed for the
rapid and sensitive detection of influenza H3N2, com-
bining anti-H3N2 Nb3 modified magnetic beads and
horseradish peroxidase (HRP)-conjugated Nb1. A sand-
wich immunoassay was used for capturing and enriching
trace amounts of H3N2 and detecting the concentration
of H3N2 with relatively high sensitivity and rapidly. The
whole procedure is schematically reviewed in Figure 1.
Methods
Immunization
A healthy young camel was immunized primarily with
pure inactivated influenza A grade 2 (H3N2) virus (1 mL,
100 μg) mixed with an equal volume of Freund’s incom-
plete adjuvant. This virus was purchased from MicrobixBiosystems Inc. (Ontario, Canada) and was inactivated by
gamma radiation. To stimulate antigen-specific B cells
to raise heavy-chain antibodies, antigen was injected
once a week. After seven injections, peripheral blood
lymphocytes (PBLs) from 100 mL of blood of the immu-
nized dromedary were isolated by density gradient using
Ficoll-Paque™ PLUS (GE Healthcare, Beijing, China) and
used to construct the library. All camel experiments
were performed according to guidelines approved by
Southeast University.
Construction of the immune single-domain antibody library
Total RNA was isolated from the purified PBLs using
the Fast Track 2.0 Kit (Invitrogen, Carsbad, CA, USA)
and to calculate the concentration. In order to avoid con-
tamination with VH genes, the variable regions of heavy-
chain immunoglobulins (VHH) were amplified by nested
PCR. One hundred nanograms of first-strand cDNA was
used in each PCR reaction with primers CALL001 and
CALL002 (Table 1). This protocol of the first PCR con-
sisted of an initial denaturation step at 94°C for 7 min,
followed by 30 cycles of 94°C for 1 min, 55°C for 1 min,
and 72°C for 1 min, and a final extension step at 72°C for
10 min. The VHH genes of the first PCR products were
analyzed by agarose gel electrophoresis. Gel plugs from
the bands near 700 base pairs (bp) were used to extract
DNA, used as template in the secondary PCR. This was
performed with the primers BACK-1, BACK-2, and PMCF
(Table 1) containing restriction enzyme sites PstI and
NotI, using the same protocol as the first PCR but reduced
to 17 cycles. The PCR products were run on 1.5% agarose
gel, and the band at approximately 400 bp was extracted
from the gel.
The amplified second PCR products were digested with
PstI and NotI restriction enzymes (NEB, Ipswich, MA,
USA), then inserted into the phagemid pMECS [18].
Ligation products were transformed into Escherichia
coli TG1 cells by electroporation. The transformants were
plated onto 2 × YT containing 1% glucose and 100 μg/mL
ampicillin and cultured at 37°C for 16 h. Plating an aliquot
of the library and counting the colony number determined
the library size. Many clones were selected randomly and
used in a colony PCR to estimate the percentage of clones
with a proper insert size within our library.
Selection of H3N2-specific nanobodies
A representative fraction of the VHH library was cul-
tured and infected with VCSM13 helper phages to ex-
press the VHH at the tip of phage particles [18]. Pure
inactivated influenza A grade 2 (H3N2) (20 μg) in coat-
ing buffer (0.1 M NaHCO3, pH 8.2) was used as antigen
to coat onto microtiter plates (Nunc Immuno Maxsorp,
Roskilde, Denmark) at 4°C overnight. The control was
0.1 M NaHCO3 (pH 8.2). After blocking with 0.1%
Figure 1 The whole procedure. Schematic representation of the strategy to select the influenza A grade 2 (H3N2)-specific single-domain
antibodies and to apply the detection approach. The H3N2-specific VHH genes were cloned and selected from an immunized dromedary.
Nanobodies identified to recognize different epitopes were used to couple with biotin or HRP to detect antigen.
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cubation with phage-displayed sdAbs in PBS for 1 h at
room temperature, the specific phages were eluted with
100 mM triethylamine, transferred to a fresh tube, and
immediately neutralized with 1.0 M Tris-HCl (pH 7.4)
and used to infect TG1 cells. This process represented
one round of panning. Then, part of the TG1 cells was
plated at various dilutions, whereas the remaining of the
culture was super-infected with helper phages VCSM13.
The generated phage particles were used in the next
round of panning. During two to four rounds of panning,






BACK-2 5′-GATGTGCAGCTGCAGGAGTCTGGGGGAGG-3′Periplasmic extract ELISA
To detect the H3N2-specific clones, 95 clones were selec-
ted randomly for periplasmic extract ELISA (PE-ELISA).
After disrupting the cells by osmotic shock and a centrifu-
gation step (i.e., the periplasmic extract), the nanobodies
resided in the supernatant, which was incubated with anti-
gen coated in microtiter plates. This technique is referred
to as periplasmic extract ELISA or PE-ELISA. Each clone
was cultured in 1 mLTerrific Broth (1 L TB: 12 g peptone,
24 g yeast extract, 4 mL glycerol, 170 mM KH2PO4,
and 0.72 M K2HPO4) with 100 μg/mL ampicillin, then
the expression of VHH by 1 mM isopropyl β-D-1-
thiogalactopyranoside (IPTG) was induced. Cells were col-
lected and resuspended into 200 μL TES (0.5 M sucrose,
0.2 M Tris-HCl pH 8.0, 0.5 mM EDTA) for 2 h at 4°C,
and 300 μL cold TES/4 was added for 2 h. The super-
natant was transferred into the wells of the microtiter
plates, in which we have coated inactivated influenza A
grade 2 (H3N2) (2 μg/mL). After 1 h, we added mouse
anti-HA tag antibody (Santa Cruz Biotechnology, Inc.,
Santa Cruz, CA, USA) for 1 h and then an anti-mouse
IgG-alkaline phosphatase (Sigma-Aldrich, Saint Louis,
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0.05% Tween 20) and addition of the chromogenic so-
lution containing bisphosphate (pNPP) (Sigma-Aldrich,
Saint Louis, MO, USA), we read the absorbance at
405 nm with an ELISA reader (Bio-Rad iMark™, Bio-Rad
Laboratories, Inc., Hercules, CA, USA).
Expression and purification of selected nanobodies
The selected VHH genes in pMECS were transformed
into E. coli WK6 electrocompetent cells to express the
nanobodies. The cells were grown in TB supplemented
with 0.1% glucose, ampicillin (100 μg/mL), and 2 mM
MgCl2, until absorbance at 600 nm reached between 0.6
and 0.9. The expression of nanobodies was subsequently
induced with 1 mM IPTG for 16 h at 28°C. After pelleting
the cells, we extracted the periplasmic proteins by osmotic
shock. Soluble sdAbs containing His-tags were purified
from the cell lysate by immobilized metal affinity chro-
matography (IMAC) using a His-Select column (Sigma-
Aldrich, Saint Louis, MO, USA). After washing with PBS,
we eluted the His-tagged proteins with a gradient of in-
creasing concentration of imidazole (pH 7.0) and subse-
quent dialysis of the fractions of interest into PBS.
ELISA for nanobody specificity detection
To detect the specificity of nanobodies which we have
purified, these nanobodies were tested to combine with
several kinds of avian influenza virus by ELISA. Each
inactivated influenza virus (5 μg/mL) was coated onto
microtiter plates overnight at 4°C in coating buffer. After
blocking with 1% bovine serum albumin (BSA) at room
temperature for 2 h, 10 μg/mL of nanobodies was added
and the plates were incubated at room temperature for 1
h. The following steps were the same as described above
for the periplasmic extract ELISA.
We then decided to detect the specificity of these two
nanobodies against the H3N2 virus. Hence, 5 μg/mL of re-
combinant hemagglutinin (HA) protein (Sino Biological
Inc., Beijing, China), H3N2 virus, and BSA (control) were
coated independently in 96-well microtiter plates, and re-
sidual protein binding sites were then blocked with 1%
skimmed milk in PBS. After incubation with nanobodies
at 10 μg/mL at room temperature for 1 h, anti-His tag
mouse monoclonal antibody (Abbkine, Inc., Redlands,
CA, USA) was added for 1 h and then anti-mouse IgG-
alkaline phosphatase for 1 h. Finally, after adding the sub-
strate, absorbance at 405 nm was read.
Conjugation with biotin in vivo
We subcloned the VHH gene fragment to a pBAD vec-
tor after digestion by NcoI and BstEII restriction endo-
nucleases and co-transformed the ligated material into
WK6 cells with pBirA plasmid [19]. The expression of
VHH-BAD fusion protein was induced with 1 mM IPTGfollowed by the addition of 50 μM D-biotin (Bio Basic
Inc., Beijing, China) and incubated for 30 min. Cells
were collected and the periplasmic proteins extracted by
osmotic shock. Soluble nanobodies, which were coupled
to biotin, were purified by Streptavidin Mutein Matrix
(Roche, Basel, Germany). After washing with PBS, the
nanobodies conjugated with biotin were eluted by 6 mM
D-biotin and dialyzed into PBS.
Coupling with HRP
To provide a detection function to the nanobodies, we
coupled HRP (Sigma-Aldrich, Saint Louis, MO, USA) to
our nanobodies. We added 100 μL fresh NaIO4 (0.1 M)
into 200 μL HRP (5 mg/mL) for 30 min at 4°C, and 200
μL ethylene glycol (2.5%) was added for 30 min at room
temperature. One milliliter of H3N2-specific nanobodies
(1 mg/L) was added to incubate overnight at 4°C.
Twenty microliters of sodium borohydride (5 mg/mL)
was mixed into it for 3 h at 4°C the next day. HRP-
conjugated nanobodies were precipitated by saturated
ammonium sulfate (SAS). The same volume of SAS was
added for 1 h at 4°C and then centrifuged at 10,000g for
30 min. Sediments were resuspended in PBS, and the
free nanobodies (i.e., non-conjugated to HRP) were re-
moved by ultrafiltration. Then, HRP-labeled nanobodies
(Nbs) were dialyzed into PBS. In order to check the effi-
ciency of the enzyme-labeled nanobody, we coated the
H3N2 antigen (5 μg/mL, 100 μL) and used the nanobo-
dies coupling with HRP (10 μg/mL, 100 mL) as detector
in our ELISA experiment. After adding 3,3′,5,5′-tetra-
methylbenzidine (Sigma-Aldrich, Saint Louis, MO, USA)
to react for 10 min and stopping the reaction with 2 M
H2SO4, the absorbance was measured at 450 nm.
Double nanobody sandwich method for antigen detection
We used 50 μL Dynabeads M-280 streptavidin (Invitrogen,
Carlsbad, CA, USA) for each reaction to capture the Nb3
conjugated with biotin (2 μg/mL) for 30 min. It was
washed with PBST for 10 times and 0.1% BSA for 2
times. After blocking with 0.1% BSA for 2 h, serial dilu-
tions of influenza A grade 2 antigen (500 μL) were added
for 1 h. The Nb1 coupled with HRP (1 μg/mL) used as a
detector was incubated for 45 min followed by washing for
15 times. All of these procedures were performed at room
temperature. Finally, we removed the free Nb1-HRP by
washing for 25 times using PBST. Then, the visualization
was carried out by adding 3,3′,5,5′-tetramethylbenzidine as
substrate. After stopping the reaction using 2 M H2SO4,
the readings were measured at 450 nm.
Temperature sensitivity test
We detected the residual binding capacity of the nano-
bodies after being incubated at 37°C for different amounts
of time. Antigen (10 μg/mL) was coated at 4°C overnight.
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with NaHCO3 (0.1 M, pH 8.2). After blocking with 1%
skimmed milk for 2 h, 20 μg/mL Nbs were added to incu-
bate for 1 h. The following steps were the same as de-
scribed for the periplasmic extract ELISA and ELISA for
evaluating the nanobody specificity. The signal with nano-
bodies that were not incubated at 37°C was considered
as 100%.
Results and discussion
Construction of immunized phage display nanobody
library
In order to isolate nanobodies against H3N2 with high
affinity and specificity, a 2-year-old healthy Bactrian camel
was immunized with the inactivated H3N2 virus over a
period of 7 weeks. After the final immunization, we tested
the antigen-specific total IgG titer within the serum from
the immunized animal and showed that 1:1,000 serum
dilution still gave a good signal. This indicated that
immunization with inactivated H3N2 has raised a good
immune response. According to the procedure in Figure 1,
the heavy-chain antibody variable region (also known as
VHH) sequences were amplified from lymphocyte cDNA
of the camel. Firstly, two PCR products including a 900 bp
fragment for VH-CH1-CH2 exons and 600 bp for VHH-
CH2 exons (Figure 2A) were amplified with primers
CALL001 and CALL002 [20]. The gene for the VHH do-
main of about 400 bp (Figure 2B) was amplified with
nested primers PMCF, BACK-1, and BACK-2 using as
template the 600 bp PCR fragment.
For library construction, two restriction enzymes, PstI
and NotI, were introduced into the 5′ and 3′ ends of the
final VHH PCR fragments, respectively. In total, 4.8 μg
of purified VHH PCR product and 16 μg of linearized
pMECS vector were used for the following ligation. AFigure 2 Library construction. (A) The segments containing VHH gene fr
amplified by a second, nested PCR. (C) Size of the library was determined b
plates containing selective antibiotics. (D) Clones were randomly selected t
insert of a proper size for a VHH.total of 30 electroporations were performed to transform
the ligation mixture into bacterial cells and to obtain a
high-quality library with great diversity. The size of the
constructed library was calculated from the number of in-
dependent colonies on plates and shown to reach 8 × 108
colonies (Figure 2C). This size of the library is about 400
times larger than the one reported previously [21]. It
should be a good starting point to retrieve antigen-specific
nanobodies. Colony PCR analysis on 24 randomly picked
colonies revealed that the percentage of colonies with
plasmids having an insert of a proper size for a VHH
reached 95% (Figure 2D). These clones have unique
sequences after sequencing their VHH fragment. All
together, these results demonstrated that we have suc-
cessfully constructed a phage display nanobody library
against H3N2.
Bio-panning of phage display library against H3N2
After getting a good quality of nanobody library for
phage display, we performed bio-panning to isolate na-
nobodies against inactivated H3N2. A total of around
2 × 1011 phage particles from the library were used in
pannings. In order to evaluate the enrichment during
the process of panning, we compared the ratio of colony
numbers between pannings on H3N2 influenza viruses and
PBS as negative control. As demonstrated in Figure 3A,B,
after two and three rounds of biopanning, the ratios have
been gradually increased from 5-fold to 67-fold. Based
on our experience, high enrichment in only three rounds
of biopanning from a large and diverse phage library is
important for a successful retrieval of antigen-specific
clones [16,22].
Next, we have randomly picked 95 colonies after pan-
ning and tested whether the PE-ELISA would reveal the
presence of nanobodies binding to inactivated H3N2. Ofagments were amplified by a first PCR. (B) The fragments were
y counting the number of clones after serial dilutions and plating on
o detect the percentage of clones with a phagemid containing an
Figure 3 H3N2-specific VHH genes were selected from the sdAb library. (A) The enrichment for phage particles in wells coated with
antigen versus wells without antigen was detected after each round of panning. Phages collected from each round were incubated with H3N2
virus and NaHCO3 (100 mM, pH 8.0), respectively. Then, the eluted phages were transformed into TG1 cells. +: Phages transformed into cells after
panning with H3N2 virus. −: Phages panning with NaHCO3 were used as control. (B) After three rounds of panning, H3N2-specific VHHs were
enriched 67-fold compared with control (+/−). (C) Periplasmic extract ELISA for 95 colonies. The colonies, whose absorbance signal (nanobodies
incubated with H3N2) is more than twofold higher than that for the negative control (nanobodies incubated with NaHCO3), were considered as
positive. (D) Four kinds of different amino acid sequences of anti-H3N2 VHHs were identified.
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binding ratios relative to a non-coated well of more than 2
(Figure 3C). VHH fragments from these 19 colonies were
further amplified by PCR and sequenced to confirm the
presence of nanobodies. Based on sequencing data, all 19
colonies contained the correct (in frame) VHH fragments.
Sequence analysis further classified these 19 nanobodies
into 4 classes, which are shown by diversified complemen-
tarity determining region 3 (CDR3) sequences (Figure 3D).
We define these four classes of nanobodies as Nb1, Nb2,
Nb3, and Nb4, respectively.
Expression of soluble nanobodies and specificity test
In order to express nanobodies in E. coli, the common
methods consist in subcloning VHH fragments from thephage display phagemid vector into an expression plas-
mid. However, in our study, we will use E. coli WK6
strains to express the nanobodies. These cells have unique
properties which cannot suppress the amber stop codon
between gene III and VHH from plasmid pMECS. In this
case, we can directly transform the VHH cloned in phage
display phagemid pMECS vector from TG1 to WK6 cells
to express nanobodies without the need for a subcloning
step. Upon IPTG induction, soluble nanobodies are ex-
pressed in the periplasmic region of WK6 cells. The
induced nanobodies were further purified by Ni2+-IDA
column. Sodium dodecyl sulfate polyacrylamide gel elec-
trophoresis (SDS-PAGE) analysis of four purified nanobo-
dies showed a good quality with more than 90% purity
after one-step purification (Figure 4A). Yields of our
Figure 4 Purification of H3N2-specific nanobodies and specificity of two paired nanobodies. (A) Four nanobodies having different
sequences were purified by immobilized metal affinity chromatography (IMAC) using a His-Select column. (B) Isoelectric point, molecular weight,
and yield of four nanobodies. (C, D) The Nb1 and Nb3, recognizing two different epitopes as shown via a pairing experiment, were chosen to
detect the specificity to five types of different viral proteins by ELISA. One hundred microliters of each inactivated influenza virus (5 μg/mL) was
coated onto microtiter plates, and 100 μL nanobodies (10 μg/mL) were added. After reaction with mouse anti-HA tag antibody and then anti-
mouse IgG-alkaline phosphatase, the chromogenic solution containing bisphosphate was added, and the absorbance at 405 nm was measured
by an ELISA reader. BSA (5 μg/mL) was used as control. Values were the means of three replicates. The values of Nb1 and Nb3 were significantly
different from the control (***P < 0.001). (E) Specificity of the nanobodies to the proteins on the surface of the H3N2 virus by ELISA. The H3N2
virus and HA protein were coated, and BSA was used as control. After incubation with Nb1 and Nb3, respectively, anti-His tag mouse monoclonal
antibody was added, and then anti-mouse IgG-alkaline phosphatase was added for detection. Finally, absorbance at 405 nm was read.
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TB medium (Figure 4B).
These four individual nanobodies showed great diver-
sity based on CDR3 sequences, and they may recognize
different epitopes of influenza H3N2. Next, we have per-
formed a nanobody-pairing assay with these four nano-
bodies. It turned out that Nb1 and Nb3 showed to be a
great combination for further diagnostic applications
based on sandwich immunoassay. As influenza A viruses
have been classified into various subtypes, we want to
know whether the isolated Nbs from our library are spe-
cific to H3N2. We then coated five different subtypes of
influenza A viruses H1N1, H3N2, H5N1, H7N2, and
H9N2 onto ELISA plates. Interestingly, Nb1 and Nb3can only recognize H3N2 (Figure 4C,D). In order to as-
sure which kind of protein on the surface of the H3N2
virus is recognized by these nanobodies, we detected its
specificity by ELISA. The result in Figure 4E showed
that Nb1 and Nb3 were specific to the hemagglutinin
protein of H3N2 virus particles. To our knowledge, this
is the first report for the identification of nanobodies
against influenza H3N2. These nanobodies might be a
promising tool to be used for sensitive detection of influ-
enza H3N2.
Expression and purification of biotinylated nanobodies
Magnetic particle-based immunoassay is a promising tool
for clinical diagnosis [23]. In this method, antibody will be
Figure 5 Purification of Nb3 conjugating with biotin and
detection of Nb1 coupling with HRP. (A) The Nb3 conjugated
with biotin was purified on a streptavidin-containing column.
(B) Analysis of the Nb1 coupled with HRP by ELISA. H3N2 antigen
was coated onto the plate directly. Nb1, coupled with HRP, was
used as a detector. After stopping the reaction, the readings were
measured at 450 nm.
Zhu et al. Nanoscale Research Letters 2014, 9:528 Page 8 of 10
http://www.nanoscalereslett.com/content/9/1/528conjugated onto magnetic beads and used as a carrier
to capture the analytes from the solution. The magnetic
beads are easy to manipulate by using an external mag-
netic field for only a very short period of time. How-
ever, the chemical conjugation of antibodies to magneticFigure 6 The use of double nanobody sandwich method for influenza
streptavidin to capture Nb3-biotin and used the Nb1 coupled to HRP as de
antigen were used for their detection. The lowest antigen concentration th
of Nb1 and Nb3 which were incubated at 37°C for different amounts of time.
after heat incubation for 48 h.particles is usually not directional. Therefore, the covalent
conjugation will lead to a decreased binding efficacy of the
antibodies. In order to overcome this problem, we decided
to label our nanobodies with biotin based on an in vivo la-
beling. Streptavidin-coated magnetic beads will incubate
with biotin-labeled nanobodies to efficiently capture the
antigens in a directional orientation. In this case, the na-
nobody conjugated on magnetic particles will be fully
functional.
In order to label nanobody with biotin in vivo
(Additional file 1: Figure S1), we took advantage of
the pBAD17 plasmid containing a biotin acceptor do-
main preceded by an IgA hinge, downstream of the Nb1
and Nb3 sequences. The plasmid was co-transformed
with the BirA plasmid (encoding for a biotin protein lig-
ase) into WK6 cells for expression. Nanobodies were
extracted from the periplasm of cells by osmotic shock
as described previously [20]. Biotinylation nanobodies
were further purified on a Streptavidin Mutein Matrix.
Finally, biotinylated Nb3 was produced at a final yield of
0.45 mg/L E. coli culture (Figure 5A). However, for an
unknown reason, we fail to obtain biotinylated Nb1 fol-
lowing the same procedure. As shown in Figure 5B,
after coupling with HRP, Nb1 was still able to recognize
inactivated influenza H3N2.A grade 2 detection. (A) We used the magnetic beads linked with
tector for H3N2 antigen detection. (B) Serial concentrations of H3N2
at could be detected was 50 ng/mL (P < 0.05). (C) The relative activity
The activity of Nb1 and Nb3 reduced 26.03% and 17.22%, respectively,
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rapid detection of influenza H3N2
Biotinylated nanobodies were attached to the magnetic
beads via a streptavidin linker. They will be used to cap-
ture influenza viral particles. After separation using a
magnetic field, HRP-labeled Nb1 was added to detect
H3N2. HRP/H2O2 catalyzed the oxidation of TMB to
form a blue-colored complex product changing to yellow
after the addition of sulfuric acid to the reaction media
[24]. The optical density (OD) value of the product was
measured to analyze the concentrations of H3N2 in the
reaction. The whole sandwich ELISA immunoassay is
summarized in Figure 6A. With the increased concentra-
tions of influenza H3N2, the binding ratio relative to BSA
(negative control) also increased. As shown in Figure 6B,
the OD value of the sample with 50 ng/mL H3N2 was sig-
nificantly higher than that for the BSA alone (negative
control) (P < 0.05). However, 10 ng/mL of H3N2 did not
show significant difference from the control (P > 0.05).
These results demonstrated that the detection limit in our
indirect ELISA assay was about 50 ng/mL, which is more
sensitive than conventional double-antibody sandwich
enzyme-linked immune sorbent assay (DAS-ELISA). Fi-
nally, we checked the stability of two H3N2 nanobodies
during different incubation times at 37°C. As shown in
Figure 6C,D, after 48 h of heat incubation, Nb1 and Nb3
keep 73.49% and 82.78% of their original antigen-binding
activity, respectively. We then investigated whether the de-
creased signal upon incubation at 37°C is due to inactiva-
tion of the antigen-binding capacity of the nanobody or
due to degradation of the detection tag. To this end, we an-
alyzed the samples incubated for different amounts of time
at an elevated temperature in SDS-PAGE and Western
blot. The result of the Western blot (Additional file 1:
Figure S2) showed that the detection tag was still present
on these nanobodies. Thus, we considered that the de-
creased signal upon incubation at 37°C is due to the de-
creased antigen-binding activity of nanobodies. Overall,
these data demonstrated that Nbs to H3N2 showed good
stability and they will provide promising diagnostic mate-
rials for clinical application.
Conclusions
We developed a rapid and sensitive immunoassay for in-
fluenza H3N2 detection based on single-domain antigen-
binding fragments of camelid-like heavy-chain antibodies.
In this study, an immune phage-displayed nanobody library
is constructed, from which four classes of nanobodies with
good affinity and specificity against H3N2 are successfully
isolated and expressed. In addition, Nb3 coupled to mag-
netic beads and HRP-conjugated Nb1 have been used for
rapid and sensitive detection of influenza H3N2. This assay
holds a great promise in providing a potentially universal
method for detecting all subtypes of influenza viruses.Additional file
Additional file 1: Supporting information. Figure S1. Schematic
overview of strategies to conjugate with biotin in vivo. H3N2-specific VHH
gene was subcloned to the pBAD plasmid, which contained the coding
gene of the biotin accepter domain. After being co-transformed into E. coli
with another plasmid pBirA, the BirA ligase produced by the BirA gene
could catalyze free biotin to combine with the VHH-BAD fusion protein.
Then, the purified VHH-BAD-biotin complex could be purified. Figure S2.
Nanobodies were not degraded after heat treatment. The two nanobodies
incubated at 37°C after 0, 2, 4, 12, 24, and 48 h were analyzed by SDS-PAGE
(A, B) and Western blot (C, D).
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